D3veloperSCS_D1versa2024-02-12T12:33:39+00:00 DIVERSA FluoGreen Peptide Delivery Reagent Peptide DIVERSA FluoGreen Peptide Delivery ReagentPeptide
D3veloperSCS_D1versa2024-02-12T14:47:00+00:00 DIVERSA Peptide Delivery Reagent Peptide DIVERSA Peptide Delivery ReagentPeptide
Exosome like-systems: key players for innovative targeted therapies Scientific news Exosome like-systems: key players for innovative targeted therapies4dm1n_diversatechnologies2024-03-26T09:03:18+00:00March 26, 2024|Scientific news|
Lipid nanoparticles: advancing your research, no matter which area you work in Scientific news Lipid nanoparticles: advancing your research, no matter which area you work in4dm1n_diversatechnologies2024-03-15T09:28:54+00:00March 15, 2024|Scientific news|
Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema Scientific news Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema4dm1n_diversatechnologies2024-02-28T10:55:25+00:00February 28, 2024|Scientific news|
Exosome like-systems: key players for innovative targeted therapies Scientific news Exosome like-systems: key players for innovative targeted therapies4dm1n_diversatechnologies2024-03-26T09:03:18+00:00March 26, 2024|Scientific news|
Lipid nanoparticles: advancing your research, no matter which area you work in Scientific news Lipid nanoparticles: advancing your research, no matter which area you work in4dm1n_diversatechnologies2024-03-15T09:28:54+00:00March 15, 2024|Scientific news|
Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema Scientific news Nanomedicine prompts the development of CRISPR-Cas9 therapies to treat hereditary angioedema4dm1n_diversatechnologies2024-02-28T10:55:25+00:00February 28, 2024|Scientific news|